Advertisement

Screening and early postnatal management strategies to prevent hazardous hyperbilirubinemia in newborns of 35 or more weeks of gestation

  • M. Jeffrey Maisels
    Correspondence
    Tel.: +1 248 551 0412; fax: +1 248 551 5998.
    Affiliations
    Department of Pediatrics, Oakland University William Beaumont School of Medicine and Division of Neonatology, Beaumont Children's Hospital, 3601 W. 13 Mile Rd., Royal Oak, Michigan 48073, USA
    Search for articles by this author
Published:December 25, 2009DOI:https://doi.org/10.1016/j.siny.2009.10.004

      Summary

      Although kernicterus is a rare condition, it is still being reported in North America and Western Europe in addition to less developed parts of the world. The majority of affected infants are term and late-preterm newborns who have been discharged from the nursery as ‘healthy newborns’ yet have subsequently developed extreme hyperbilirubinemia and the classic neurodevelopmental findings associated with kernicterus. Published guidelines provide the basic tools for preventing hazardous hyperbilirubinemia and the two most important of these are a systematic assessment, prior to discharge, of each infant, for the risk of severe hyperbilirubinemia, and appropriate follow-up based on the time of discharge and the risk assessment. The most recent recommendations call for a predischarge measurement of the serum or transcutaneous bilirubin in all infants. When combined with the gestational age and other risk factors for hyperbilirubinemia, this provides the best estimate of the risk, or lack of risk, for subsequent hyperbilirubinemia, and determines the timing of follow-up and the need for further evaluation and treatment. The application of these principles to the management of the jaundiced newborn might not eliminate every case of kernicterus, but should contribute to a reduction in its occurrence.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Seminars in Fetal and Neonatal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Watchko J.F.
        Exchange transfusion in the management of neonatal hyperbilirubinemia.
        in: Maisels M.J. Watchko J.F. Neonatal jaundice. Harwood, London2000: 169-176
        • Johnson L.
        • Bhutani V.K.
        • Karp K.
        • Sivieri E.M.
        • Shapiro S.M.
        Clinical report from the pilot USA kernicterus registry (1992 to 2004).
        J Perinatol. 2009; 29: S25-S45
        • Maisels M.J.
        • Newman T.B.
        Kernicterus in otherwise healthy, breast-fed term newborns.
        Pediatrics. 1995; 96: 730-733
        • Sgro M.
        • Campbell D.M.
        • Fallah S.
        • Shah V.
        Kernicterus–January 2007 to December 2009. Canadian Paediatric Surveillance Program 2009.
        (Available at:)
        • Manning D.
        • Todd P.
        • Maxwell M.
        • Platt M.-J.
        Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland.
        Arch Dis Child Fetal Neonatol Ed. 2007; 92: 342-346
        • Ebbesen F.
        Recurrence of kernicterus in term and near-term infants in Denmark.
        Acta Paediatr. 2000; 89: 1213-1217
        • Banerjee T.K.
        • Hazra A.
        • Biswas A.
        • Ray J.
        • et al.
        Neurological disorders in children and adolescents.
        Ind J Pediatr. 2009; 76: 139-146
        • Mezaal M.A.
        • Nouri K.A.
        • Abdool S.
        • Safar K.A.
        • Nadeem A.S.M.
        Cerebral palsy in adults. Consequences of non progressive pathology.
        Open Neuro J. 2009; 3: 24-26
        • Slusher T.M.
        • Vreman H.J.
        • McLaren D.
        • et al.
        Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin related morbidity and death in Nigerian infants.
        J Pediatr. 1995; 126: 102-108
        • Ebbesen F.
        • Andersson C.
        • Verder H.
        • et al.
        Extreme hyperbilirubinaemia in term and near-term infants in Denmark.
        Acta Paediatr. 2005; 94: 59-64
        • American Academy of Pediatrics
        Subcommittee on hyperbilirubinemia. Clinical practice guideline: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.
        Pediatrics. 2004; 114: 297-316
        • Canadian Paediatric Society
        Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation).
        Paediatr Child Health. 2007; 12: 1B-12
        • Maisels M.J.
        • Bhutani V.K.
        • Bogen D.
        • Newman T.B.
        • Stark A.R.
        • Watchko J.F.
        Hyperbilirubinemia in the newborn infant ≥35 weeks' gestation: an update with clarifications.
        Pediatrics. 2009; 124: 1193-1198
        • Bertini G.
        • Dani C.
        • Trochin M.
        • Rubaltelli F.
        Is breast feeding really favoring early neonatal jaundice?.
        Pediatrics. 2001; (Available at:): 107
        • Newman T.B.
        • Xiong B.
        • Gonzales V.M.
        • Escobar G.J.
        Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization.
        Arch Pediatr Adolesc Med. 2000; 154: 1140-1147
        • Maisels M.J.
        • Gifford K.
        Normal serum bilirubin levels in the newborn and the effect of breast feeding.
        Pediatrics. 1986; 78: 837-843
        • Maisels M.J.
        • DeRidder J.M.
        • Kring E.A.
        • Balasubramaniam M.
        Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia.
        J Perinatol. 2009; 29: 612-617
        • Schneider A.P.
        Breast milk jaundice in the newborn. A real entity.
        J Am Med Assoc. 1986; 255: 3270-3274
        • Maisels M.J.
        • Gifford K.
        • Antle C.E.
        • Leib G.R.
        Jaundice in the healthy newborn infant: a new approach to an old problem.
        Pediatrics. 1988; 81: 505-511
        • De Carvalho M.
        • Klaus M.H.
        • Merkatz R.B.
        Frequency of breastfeeding and serum bilirubin concentration.
        Am J Dis Child. 1982; 136: 737-738
        • Yamauchi Y.
        • Yamanouchi I.
        Breast-feeding frequency during the first 24 hours after birth in full-term neonates.
        Pediatrics. 1990; 86: 171-175
        • Gourley G.R.
        Breast-feeding, neonatal jaundice and kernicterus.
        Semin Neonatol. 2002; 7: 135-141
        • Auerbach K.G.
        • Gartner L.M.
        Breast feeding and human milk: their association with jaundice in the neonate.
        Clin Perinatol. 1987; 14: 89-107
        • Gärtner U.
        • Goeser T.
        • Wolkoff A.W.
        Effect of fasting on the uptake of bilirubin and sulfobromophthalein by the isolated perfused rat liver.
        Gastroenterology. 1997; 113: 1707-1713
        • Fevery J.
        Fasting hyperbilirubinemia: unraveling the mechanism involved.
        Gastroenterology. 1997; 113: 1798-1800
        • De Carvalho M.
        • Robertson S.
        • Klaus M.
        Fecal bilirubin excretion and serum bilirubin concentration in breast-fed and bottle-fed infants.
        J Pediatr. 1985; 107: 786-790
        • Gourley G.R.
        • Kreamer B.
        • Arend R.
        The effect of diet on feces and jaundice during the first three weeks of life.
        Gastroenterology. 1992; 103: 660
        • Verkade H.J.
        A novel hypothesis on the pathophysiology of neonatal jaundice.
        J Pediatr. 2002; 141: 594-595
        • Nishioka T.
        • Hafkamp A.M.
        • Havinga R.
        • Van Lierop P.P.E.
        • Velvis H.
        • Verkade H.J.
        Orlistat treatment increases fecal bilirubin excretion and decreases plasma bilirubin concentrations in hyperbilirubinemic gunn rats.
        J Pediatr. 2003; 143: 327-334
        • Gourley G.R.
        Pathophysiology of breast-milk jaundice.
        in: Polin R.A. Fox W.W. Fetal and neonatal physiology. Saunders, Philadelphia1998: 1499
        • Yoshioka H.
        Development and differences of intestinal flora in the neonatal period in breast-fed and bottle-fed infants.
        Pediatrics. 1983; 72: 317-321
        • Gourley G.R.
        • Arend R.A.
        Beta-glucuronidase and hyperbilirubinemia in breast-fed and formula-fed babies.
        Lancet. 1986; 1: 644-646
        • Sirota L.
        • Ferrera M.
        • Lerer N.
        • Dulitzky F.
        Beta-glucuronidase and hyperbilirubinaemia in breast fed infants of diabetic mothers.
        Arch Dis Child. 1992; 67: 120-121
        • Monaghan G.
        • McLellan A.
        • McGeehan A.
        • et al.
        Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.
        J Pediatr. 1999; 134: 441-446
        • Maisels M.J.
        Jaundice.
        in: MacDonald M.G. Seshia M.M.K. Mullett M.D. Avery's Neonatology. Lippincott Co., Philadelphia, PA2005: 768-846
        • Maisels M.J.
        • Kring E.
        Transcutaneous bilirubin levels in the first 96 hours in a normal newborn population of 35 or more weeks' of gestation.
        Pediatrics. 2006; 117: 1169-1173
        • Bhutani V.K.
        • Johnson L.
        • Sivieri E.M.
        Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy-term and near-term newborns.
        Pediatrics. 1999; 103: 6-14
        • Davidson L.T.
        • Merritt K.K.
        • Weech A.A.
        Hyperbilirubinemia in the newborn.
        Am J Dis Child. 1941; 61: 958-980
        • Moyer V.A.
        • Ahn C.
        • Sneed S.
        Accuracy of clinical judgment in neonatal jaundice.
        Arch Pediatr Adolesc Med. 2000; 154: 391-394
        • Kramer L.I.
        Advancement of dermal icterus in the jaundiced newborn.
        Am J Dis Child. 1969; 118: 454-458
        • Madlon-Kay D.J.
        Recognition of the presence and severity of newborn jaundice by parents, nurses, physicians, and icterometer.
        Pediatrics. 1997; 100: e3
        • Riskin A.
        • Abend-Weinger M.
        • Bader D.
        How accurate are neonatologists in identifying clinical jaundice in newborns?.
        Clin Pediatr. 2003; 42: 153-158
        • Szabo P.
        • Wolf M.
        • Bucher H.U.
        • Fauchère J.C.
        • Haensse D.
        • Arlettaz R.
        Detection of hyperbilirubinaemia in jaundiced full-term neonates by eye or by bilirubinometer?.
        Eur J Pediatr. 2004; 163: 722-727
        • Keren R.
        • Luan X.
        • Friedman S.
        • Saddlemire S.
        • Cnaan A.
        • Bhutani V.
        A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants.
        Pediatrics. 2008; 121: e170-179
        • Maisels M.J.
        • DeRidder J.
        • Kring E.
        Transcutaneous bilirubin (TcB) levels in outpatient practice.
        E-PAS. 2007; : 618441.5
        • Engle W.
        • Jackson G.C.
        • Stehel E.K.
        • Sendelbach D.
        • Manning M.D.
        Evaluation of a transcutaneous jaundice meter following hospital discharge in term and near-term neonates.
        J Perinatol. 2005; 25: 486-490
        • Maisels M.J.
        • Artinian F.
        • Engle W.
        • McManus S.
        • Wainer S.
        Transcutaneous bilirubin (TcB) levels in a mixed race outpatient population – use of a new approach.
        E-PAS. 2009; : 2842.398
        • Maisels M.J.
        Transcutaneous bilirubinometry.
        Neoreviews. 2006; 7: e217-e225
        • Maisels M.J.
        • Kring E.
        Trancutaneous bilirubinometry decreases the need for serum bilirubin measurements and saves money.
        Pediatrics. 1997; 99: 599-601
        • Dai J.
        • Krahn J.
        • Parry D.M.
        Clinical impact of transcutaneous bilirubinometry as an adjunctive screen for hyperbilirubinemia.
        Clin Biol. 1996; 29: 581-586
        • Ebbesen F.
        • Rasmussen L.M.
        • Wimberley P.D.
        A new transcutaneous bilirubinometer, BiliCheck, used in the neonatal intensive care unit and the maternity ward.
        Acta Paediatr. 2002; 91: 203-211
        • Stevenson D.K.
        • Fanaroff A.A.
        • Maisels M.J.
        • et al.
        Prediction of hyperbilirubinemia in near-term and term infants.
        Pediatrics. 2001; 108: 31-39
        • Alpay F.
        • Sarici S.
        • Tosuncuk H.D.
        • Serdar M.A.
        • Inanc N.
        • Gokcay E.
        The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns.
        Pediatrics. 2000; 106: E16
        • Carbonell X.
        • Botet F.
        • Figueras J.
        • Riu-Godo A.
        Prediction of hyperbilirubinaemia in the healthy term newborn.
        Acta Paediatr. 2001; 90: 166-170
        • Kaplan M.
        • Hammerman C.
        • Feldman R.
        • Brisk R.
        Predischarge bilirubin screening in glucose-6-phosphate dehydrogenase-deficient neonates.
        Pediatrics. 2000; 105: 533-537
        • Newman T.
        • Liljestrand P.
        • Escobar G.
        Combining clinical risk factors with bilirubin levels to predict hyperbilirubinemia in newborns.
        Arch Pediatr Adolesc Med. 2005; 159: 113-119
        • Newman T.B.
        Universal bilirubin screening, guidelines, and evidence.
        Pediatrics. 2009; 124: 1199-1202
        • Trikalinos T.
        • Chung M.
        • Lau J.
        • Ip S.
        Systematic review of screening for bilirubin encephalopathy in neonates.
        Pediatrics. 2009; 124: 1162-1171
        • US Preventive Services Task Force (USPSTF)
        Screening of infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy: U.S. Preventive Services Task Force recommendation statement.
        Pediatrics. 2009; 124: 1172-1177
        • Kuzniewicz M.W.
        • Escobar G.J.
        • Newman T.B.
        The impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use in a managed care organization.
        Pediatrics. 2009; 124: 1031-1039
        • Eggert L.
        • Wiedmeier S.E.
        • Wilson J.
        • Christensen R.
        The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system.
        Pediatrics. 2006; 117: e855-e862
        • Longhurst C.
        • Turner S.
        • Burgos A.E.
        Development of a web-based decision support tool to increase use of neonatal hyperbilirubinemia guidelines.
        Jt Comm J Qual Patient Saf. 2009; 35: 256-262
        • National Quality Forum
        Serious reportable events in healthcare: a consensus report.
        National Quality Forum, Washington, DC2002
        • Davidson L.
        • Thilo E.H.
        How to make kernicterus a “never event”.
        Neoreviews. 2003; 4: 308-314
        • Auerbach A.D.
        • Landefeld C.S.
        • Shojania K.
        The tension between needing to improve care and knowing how to do it.
        N Engl J Med. 2007; 357: 608-613
      1. *The most important references are indicated with an asterisks.